PDB Short entry for 6VY8 HEADER BIOSYNTHETIC PROTEIN 25-FEB-20 6VY8 TITLE NMR SOLUTION STRUCTURE OF A TRIAZOLE BRIDGED TRYPSIN INHIBITOR BASED TITLE 2 ON THE FRAMEWORK OF SFTI-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN INHIBITOR GLY-ARG-RVJ-THR-LYS-SER-ILE-PRO-PRO-ILE- COMPND 3 2AG-PHE-PRO-ASP; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELIANTHUS ANNUUS; SOURCE 4 ORGANISM_COMMON: COMMON SUNFLOWER; SOURCE 5 ORGANISM_TAXID: 4232 KEYWDS TRIAZOLE, DISULFIDE MIMETIC, INHIBITOR, BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.M.WHITE,P.J.HARVEY,T.DUREK,D.J.CRAIK REVDAT 2 15-NOV-23 6VY8 1 LINK ATOM REVDAT 1 01-JUL-20 6VY8 0 JRNL AUTH A.M.WHITE,S.J.DE VEER,G.WU,P.J.HARVEY,K.YAP,G.J.KING, JRNL AUTH 2 J.E.SWEDBERG,C.K.WANG,R.H.P.LAW,T.DUREK,D.J.CRAIK JRNL TITL APPLICATION AND STRUCTURAL ANALYSIS OF TRIAZOLE-BRIDGED JRNL TITL 2 DISULFIDE MIMETICS IN CYCLIC PEPTIDES. JRNL REF ANGEW.CHEM.INT.ED.ENGL. 2020 JRNL REFN ESSN 1521-3773 JRNL PMID 32270580 JRNL DOI 10.1002/ANIE.202003435 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1000247270. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NA REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5 MM DR10, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H E.COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, CCPNMR ANALYSIS, TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE CYCLIC TRYPSIN INHIBITOR IS POLYPEPTIDE, A MEMBER OF TRYPSIN REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLIC TRYPSIN INHIBITOR REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND RVJ A 3 C1A 2AG A 11 2.13 REMARK 500 NE RVJ A 3 C1E 2AG A 11 2.17 REMARK 500 ND RVJ A 3 C1E 2AG A 11 2.19 REMARK 500 NG RVJ A 3 C1A 2AG A 11 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 4 ARG A 2 83.61 57.92 REMARK 500 6 PRO A 13 4.34 -65.18 REMARK 500 9 LYS A 5 48.40 -81.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6U22 RELATED DB: PDB REMARK 900 RELATED ID: 6U24 RELATED DB: PDB REMARK 900 RELATED ID: 30729 RELATED DB: BMRB REMARK 900 NMR SOLUTION STRUCTURE OF A TRIAZOLE BRIDGED TRYPSIN INHIBITOR REMARK 900 BASED ON THE FRAMEWORK OF SFTI-1 DBREF 6VY8 A 1 14 PDB 6VY8 6VY8 1 14 SEQRES 1 A 14 GLY ARG RVJ THR LYS SER ILE PRO PRO ILE 2AG PHE PRO SEQRES 2 A 14 ASP HET RVJ A 3 12 HET 2AG A 11 12 HETNAM RVJ 3-TRIAZAN-1-YL-L-ALANINE HETNAM 2AG (2S)-2-AMINOPENT-4-ENOIC ACID HETSYN 2AG L-ALLYLGLYCINE FORMUL 1 RVJ C3 H10 N4 O2 FORMUL 1 2AG C5 H9 N O2 SHEET 1 AA1 2 RVJ A 3 THR A 4 0 SHEET 2 AA1 2 ILE A 10 2AG A 11 -1 O ILE A 10 N THR A 4 LINK N GLY A 1 C ASP A 14 1555 1555 1.33 LINK C ARG A 2 N RVJ A 3 1555 1555 1.29 LINK C RVJ A 3 N THR A 4 1555 1555 1.30 LINK NG RVJ A 3 C1E 2AG A 11 1555 1555 1.36 LINK NE RVJ A 3 C1A 2AG A 11 1555 1555 1.32 LINK C ILE A 10 N 2AG A 11 1555 1555 1.31 LINK C 2AG A 11 N PHE A 12 1555 1555 1.29 CISPEP 1 ILE A 7 PRO A 8 1 -1.05 CISPEP 2 ILE A 7 PRO A 8 2 -4.02 CISPEP 3 ILE A 7 PRO A 8 3 -1.82 CISPEP 4 ILE A 7 PRO A 8 4 -4.79 CISPEP 5 ILE A 7 PRO A 8 5 -0.32 CISPEP 6 ILE A 7 PRO A 8 6 1.07 CISPEP 7 ILE A 7 PRO A 8 7 2.31 CISPEP 8 ILE A 7 PRO A 8 8 -2.52 CISPEP 9 ILE A 7 PRO A 8 9 -2.98 CISPEP 10 ILE A 7 PRO A 8 10 -0.10 CISPEP 11 ILE A 7 PRO A 8 11 0.95 CISPEP 12 ILE A 7 PRO A 8 12 -2.41 CISPEP 13 ILE A 7 PRO A 8 13 -2.40 CISPEP 14 ILE A 7 PRO A 8 14 -2.78 CISPEP 15 ILE A 7 PRO A 8 15 1.12 CISPEP 16 ILE A 7 PRO A 8 16 -3.80 CISPEP 17 ILE A 7 PRO A 8 17 -2.75 CISPEP 18 ILE A 7 PRO A 8 18 -4.77 CISPEP 19 ILE A 7 PRO A 8 19 -0.87 CISPEP 20 ILE A 7 PRO A 8 20 -2.15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000